About Technology Issues FAQ

Links

Official Page

Obinutuzumab (GA101) plus CHOP or FC in relapsed/refractory follicular lymphoma: results of the GAUDI study (BO21000)

Obinutuzumab (GA101) plus CHOP or FC in relapsed/refractory follicular lymphoma: results of the GAUDI study (BO21000) — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.